| Features: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Found in roots, leaves, nut-hulls, bark and wood of walnut trees. Juglone (5-hydroxy-1,4-naphthoquinone) Juglans nigra refers to the black walnut tree, which is one of the most well-known sources of juglone -Research has focused on the hulls (the green outer covering of the walnut) because they have the highest concentrations. -Fresh hulls can contain juglone levels in the range of approximately 1–5% of the dry weight -Juglone can redox cycle to generate reactive oxygen species (ROS). -Increasing Bax, decreasing Bcl‑2, caspase activation, and MMP depolarization. -Modulation of MAPK pathways (including ERK, JNK, and p38) -May inhibit NF‑κB signaling -Cause DNA damage or stress that, in turn, leads to p53 pathway activation— Pin1 Inhibition –Pin1, a peptidyl-prolyl cis/trans isomerase, is frequently overexpressed in cancer. -ic50 maybe 5-10uM -For matching 5uM, crude estimate is 5mg consumption of juglone required which might be 1.5 g of black walnut hull material
|
| Source: |
| Type: |
| Also known as Cadherin2 (CDH2). N-cadherin is a type of cell adhesion molecule that plays a crucial role in the development and maintenance of tissue structure. In the context of cancer, N-cadherin has been implicated in the progression and metastasis of various types of tumors. N-cadherin expression is increased in various types of cancer. Normally, N-cadherin is expressed in mesenchymal cells, such as fibroblasts and smooth muscle cells. However, in cancer cells, N-cadherin expression is often upregulated, which can contribute to the epithelial-to-mesenchymal transition (EMT). EMT is a process by which epithelial cells acquire a more mesenchymal phenotype, which is characterized by increased motility, invasiveness, and resistance to apoptosis. The expression of N-cadherin in cancer cells is closely associated with tumorigenesis and metastasis. Additionally, the soluble N-cadherin level in the serum of cancer patients is much higher than that in the serum of healthy patients, revealing a positive relation with poor prognosis. |
| 5115- | JG, | Natural Products to Fight Cancer: A Focus on Juglans regia |
| - | Review, | Var, | NA |
| 1121- | JG, | Juglone suppresses epithelial-mesenchymal transition in prostate cancer cells via the protein kinase B/glycogen synthase kinase-3β/Snail signaling pathway |
| - | in-vitro, | Pca, | LNCaP |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:105 Target#:355 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid